| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |